Allan Jonathan

CIK 1966716
Transactions on file
28

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-06-182026-06-16STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale1,457$43.6K-2.2%open →
2025-03-182025-03-15STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Exer.7,475$0.00open →
2025-03-182025-03-15STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Exer.6,000$0.00open →
2025-03-202025-03-18STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Sale2,266$19.6K+237.9%open →
2025-03-202025-03-19STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Sale1,945$16.1K+254.3%open →
2025-12-102025-12-08STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale2,678$87.3K-10.2%open →
2025-12-102025-12-08STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale1,300$41.1K-7.3%open →
2025-12-052025-12-05STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale2,344$74.4K-7.7%open →
2025-12-052025-12-05STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale5,437$169.0K-5.7%open →
2025-12-052025-12-05STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale1,004$31.5K-6.5%open →
2025-12-052025-12-04STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale194$6.1K-6.4%open →
2025-12-052025-12-04STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale824$25.3K-4.8%open →
2025-12-052025-12-03STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Exer.6,000$0.00open →
2025-12-032025-12-03STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale1,394$43.0K-5.0%open →
2025-12-032025-12-03STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale898$27.2K-3.4%open →
2025-12-032025-12-02STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale868$26.2K-2.8%open →
2025-12-032025-12-02STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale1,416$41.9K-0.9%open →
2025-12-032025-12-01STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Exer.12,357$0.00open →
2025-10-072025-10-03STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Sale10,000$250.7K+16.9%open →
2025-10-072025-10-03STOK
Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
Exer.10,000$91.5K+220.2%open →
2025-08-152025-08-13STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Sale13,712$205.7K+95.3%open →
2025-08-182025-08-14STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Exer.6,000$0.00open →
2025-08-202025-08-18STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Sale1,683$30.7K+60.6%open →
2025-09-032025-09-02STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Exer.9,150$64.7K+314.4%open →
2025-09-032025-09-02STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Sale14,922$300.5K+45.5%open →
2025-09-032025-09-03STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Sale6,345$127.3K+46.0%open →
2025-09-032025-08-29STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Sale850$17.0K+46.5%open →
2025-09-032025-08-29STOK
Stoke Therapeutics, Inc.
Officer
GENERAL COUNSEL & CORP SEC
Exer.850$6.0K+314.4%open →